Cargando…
Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer
Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death worldwide. Numerous drugs have been developed to treat lung cancer patients in recent years, whereas most of these drugs have undesirable adverse effects due to nonspecific distribution in the body. To address th...
Autores principales: | Lin, Xu, Wu, Jiahe, Liu, Yupeng, Lin, Nengming, Hu, Jian, Zhang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838081/ https://www.ncbi.nlm.nih.gov/pubmed/35164213 http://dx.doi.org/10.3390/molecules27030948 |
Ejemplares similares
-
Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
por: Jia, Ruixin, et al.
Publicado: (2021) -
Stimuli-responsive drug delivery systems for head and neck cancer therapy
por: Liang, Jingou, et al.
Publicado: (2021) -
Stimuli-responsive polymeric micelles for drug delivery and cancer therapy
por: Zhou, Qing, et al.
Publicado: (2018) -
Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
por: Zhang, Mi, et al.
Publicado: (2022) -
Advances and Challenges of Stimuli-Responsive Nucleic Acids Delivery System in Gene Therapy
por: Lin, Meng, et al.
Publicado: (2023)